• 7100 Cambridge Research Park
  • Waterbeach
  • Cambridge, GB
  • CB25 9TL


Horizon is a UK biotechnology company that combines a long scientific heritage in translational research with a world-leading gene-editing platform based upon homologous recombination. The Company is a trusted supplier of genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. Horizon aspires to provide science-driven research solutions that lead to the advancement in the understanding of the genetic basis of disease and the delivery of better healthcare outcomes for patients.

11 Horizon products on LabWrench

Horizon Cell Free DNA HDx Reference Standards

Found In: Assays

The emergence of non-invasive disease assessment and progression monitoring has resulted in the development of many new cell-free DNA (cfDNA) assays.

Horizon IHC HDx™ Reference Standards

Found In: Assays

IHC HDx Reference Standards provide laboratories with a consistent source of positive and negative reference material on one slide.

Horizon GENASSIST™ CRISPR & rAAV Genome Editing Tools

Found In: Software

Successful CRISPR genome editing relies on the quality of the gRNA design, and that requires the best bioinformatic software. gUIDEbook™ from

See all 11 Horizon products on LabWrench

News About Horizon

Image: Horizon Discovery introduces whole human genome arrayed libraries to support CRISPR activation screening

·         First-to-market Edit-R CRISPRa arrayed crRNA libraries enable native gene overexpression for high-throughput gain-of-function screening ·      ...

Image: Horizon Discovery introduces Multiplex cfDNA Reference Standard for EGFR mutations to support liquid biopsy assays

  Horizon Discovery (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announces the launch of its new cell line-derived epidermal growth factor receptor...

Image: Horizon: 5-Fusion Multiplex FFPE RNA Reference Standard

The 5-Fusion Multiplex FFPE RNA Reference Standard from Horizon Discovery is a highly-characterized, biologically-relevant quality control material used to assess the performance of targeted NGS, RT-PCR and RT-qPCR assays aimed...

Image: Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation

Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its...

Image: Horizon Discovery partners with The Michael J. Fox Foundation to introduce novel pre-clinical models for Parkinson’s Disease

Horizon Discovery (LSE: HZD) (“Horizon”), a global leader in gene editing and gene modulation technologies, in partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF), today introduced two new gene knock-out...

Ask a Question

About Horizon


Add a Post to Browse Categories Questions and Answers